|
Versatile multigene expression biomarker for predicting clinical platinum sensitivity in non-small cell lung cancer (NSCLC) and ovarian cancer (OC). |
| |
|
Employment - Medical Prognosis Institute (I) |
Leadership - Medical Prognosis Institute (I) |
Stock and Other Ownership Interests - Medical Prognosis Institute (I) |
| |
|
Honoraria - Medical Prognosis Institute |
Consulting or Advisory Role - Medical Prognosis Institute |
| |
|
Employment - Medical Prognosis Institute |
Stock and Other Ownership Interests - Medical Prognosis Institute; Medical Prognosis Institute (I) |
Honoraria - Medical Prognosis Institute |
Travel, Accommodations, Expenses - Medical Prognosis Institute |
Other Relationship - Medical Prognosis Institute |
| |
|
Employment - Medical Prognosis Institute |
Leadership - Medical Prognosis Institute |
Stock and Other Ownership Interests - Medical Prognosis Institute |
Honoraria - Medical Prognosis Institute |
Travel, Accommodations, Expenses - Medical Prognosis Institute |
| |
|
Employment - Medical Prognosis Institute; WntResearch |
Leadership - Medical Prognosis Institute; WntResearch |
Stock and Other Ownership Interests - Medical Prognosis Institute; WntResearch |
Consulting or Advisory Role - Medical Prognosis Institute; WntResearch |
Travel, Accommodations, Expenses - Medical Prognosis Institute |
| |
|
Employment - LiPlasome Pharma; Medical Prognosis Institute; Oncology Venture; WntResearch |
|
Stock and Other Ownership Interests - Exiqon; Oncology Venture; WntResearch |
Consulting or Advisory Role - Medical Prognosis Institute |
Travel, Accommodations, Expenses - WntResearch |
| |
|
Employment - LiPlasome Pharma |
Leadership - LiPlasome Pharma |
Stock and Other Ownership Interests - Medical Prognosis Institute |
Honoraria - LiPlasome Pharma |
Patents, Royalties, Other Intellectual Property - LiPlasome Pharma |
Travel, Accommodations, Expenses - LiPlasome Pharma |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - Novo Nordisk |
| |
|
Honoraria - Novartis; Pfizer; Roche Pharma AG |
Consulting or Advisory Role - Pfizer |
Travel, Accommodations, Expenses - Pfizer; Roche Pharma AG |
| |
|
Employment - Medical Prognosis Institute |
Stock and Other Ownership Interests - Medical Prognosis Institute |
| |
|
Employment - Medical Prognosis Institute |
Leadership - Medical Prognosis Institute |
Stock and Other Ownership Interests - Medical Prognosis Institute |
Honoraria - Medical Prognosis Institute |
| |
|
Employment - Medical Prognosis Institute |
Leadership - Medical Prognosis Institute |
Stock and Other Ownership Interests - Medical Prognosis Institute |